Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00090844 · ClinicalTrials.gov registry record · Phase 2
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
A Phase 2 study, sponsored by University of South Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00090844 is a Phase 2 study that was terminated before completion, run by University of South Florida. The registered enrollment target is 49 participants.
The verdict
NCT00090844, a Phase 2 study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs, such as triptorelin, may protect normal ovarian cells from the side effects of chemotherapy. PURPOSE: This randomized phase II trial is studying how well triptorelin works in preserving ovarian function in premenopausal women who are receiving chemotherapy for early-stage breast cancer.
Interventions
- DRUG triptorelin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00090844
The ClinicalTrials.gov registry entry for NCT00090844 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which triptorelin is the first listed.
NCT00090844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00090844 about?
NCT00090844 is a clinical study titled "Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer". RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs, such as triptorelin, may protect normal ovarian cells from the side effects of chemotherapy. PURPOSE: This randomized phase II trial is studying how wel...
What is the current status of trial NCT00090844?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2004-07. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00090844?
The interventions under investigation include: triptorelin (DRUG).
Who is sponsoring clinical trial NCT00090844?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.